Dorsey Wright & Associates Alpine Immune Sciences, Inc. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$10.13 - $13.98 $790 - $1,090	-78 Reduced 3.32%	2,273 $26,000
Q2 2023 Jul 26, 2023	BUY	$6.84 - $11.91 $16,080 - $28,000	2,351 New	2,351 $24,000
Q2 2021 Jul 23, 2021	SELL	$8.81 - $15.03 $29,777 - $50,801	-3,380 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$10.02 - $13.92 $33,867 - $47,049	3,380 New	3,380 $35.8 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.